Acadian Asset Management
HRMY icon

Acadian Asset Management’s Harmony Biosciences HRMY Stock Holding History

Acadian Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.83M Buy
215,400
+84,651
+65% +$2.67M 0.01% 672
2026
Q1 		$3.65M Buy
130,749
+108,209
+480% +$3.55M 0.01% 786
2025
Q4 		$841K Sell
22,540
-25,663
-53% -$844K ﹤0.01% 1158
2025
Q3 		$1.32M Buy
48,203
+26,026
+117% +$897K ﹤0.01% 987
2025
Q2 		$699K Sell
22,177
-116,298
-84% -$3.74M ﹤0.01% 1065
2025
Q1 		$4.59M Buy
+138,475
New +$4.96M 0.01% 525
2024
Q4 		– Sell
-4,819
Closed -$192K – 1862
2024
Q3 		$192K Buy
+4,819
New +$169K ﹤0.01% 1382
2022
Q4 		– Sell
-2,724
Closed -$120K – 1840
2022
Q3 		$120K Hold
2,724
– – ﹤0.01% 1323
2022
Q2 		$133K Sell
2,724
-643
-19% -$28.9K ﹤0.01% 1293
2022
Q1 		$163K Buy
3,367
+1,383
+70% +$56.4K ﹤0.01% 1254
2021
Q4 		$84K Buy
+1,984
New +$79.1K ﹤0.01% 1411

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management's HRMY Position: Q2 2026 in Review

Acadian Asset Management increased its Harmony Biosciences (HRMY) stake by 65% in Q2 2026, buying an estimated $2.67M and bringing the position to 215,400 shares worth $7.83M. The position accounts for 0.01% of the portfolio, ranked #672.

Acadian Asset Management first reported a position in HRMY in Q4 2021 and has held it in 11 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Acadian Asset Management held 215,400 shares of Harmony Biosciences worth $7.83M as of Q2 2026.
  • Acadian Asset Management bought 84,651 Harmony Biosciences shares in Q2 2026, an estimated $2.67M.
  • Harmony Biosciences made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #672 holding.
  • Acadian Asset Management first reported a position in Harmony Biosciences in Q4 2021 and has held it in 11 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.